’’ ”Valeant Pharmaceuticals’ stock is falling for the second day in a row on the release of  the company’s .” ”In it, Valeant detailed a number of investigations into the company, including a previously disclosed SEC is investigation into the pharma company’s subsidiary Salix, which Valeant acquired in 2015 for :” ’’ ’’ ’’ ’’ ’ ’ ”Valeant Pharmaceuticals’ stock is falling for. ..” ’’ ’’ ’’